🇺🇸 FDA
Patent

US 7582651

Pyrrolopyridine derivative and use thereof

granted A61PA61P13/00A61P13/02

Quick answer

US patent 7582651 (Pyrrolopyridine derivative and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P13/00, A61P13/02, A61P13/10, A61P25/04